Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts. - Wikidata - wikimedia - TriplyDB

Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts.

Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts.

http://www.wikidata.org/entity/Q37701607

about

Function of neuronal nitric oxide synthase enzyme in temozolomide-induced damage of astrocytic tumor cells.

P2860

Q52649753-3095C64A-C054-4C3A-B145-726F9250F79E

P2860

Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts.

http://www.wikidata.org/entity/Q37701607

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Radiolabeled novel mAb 4G1 for ...... nical glioblastoma xenografts.

@en

Radiolabeled novel mAb 4G1 for ...... nical glioblastoma xenografts.

@nl

type

label

Radiolabeled novel mAb 4G1 for ...... nical glioblastoma xenografts.

@en

Radiolabeled novel mAb 4G1 for ...... nical glioblastoma xenografts.

@nl

prefLabel

Radiolabeled novel mAb 4G1 for ...... nical glioblastoma xenografts.

@en

Radiolabeled novel mAb 4G1 for ...... nical glioblastoma xenografts.

@nl

P1433

Q37701607-1175CDEF-3B52-4BAD-8414-5700B61926A0

P1476

Q37701607-F2970E23-ADB1-4B29-B83C-4A4B390F07D4

P2093

Q37701607-147782DF-3ABE-4CCD-9A9D-E71CF1066DF1

Q37701607-18164D3D-1098-48C8-8E30-C663A8C4377D

Q37701607-1DEDF189-54AA-4245-A327-7D4D0EBC5268

Q37701607-236F566E-B47B-42C3-8559-21E44EBEF7F8

Q37701607-3A3070D0-F5B7-4E50-BD0C-A2370CA669F9

Q37701607-5B90F6F7-89CF-4C60-A54A-DB75F63BF514

Q37701607-7307A6F7-8B3C-4068-A591-178ADC5168A0

Q37701607-A4368991-8FC4-47F1-9860-4E84387A6BC2

Q37701607-D81785AB-61B1-4C39-814D-1D0F4B8AFA54

P2860

Q37701607-03A9E159-1E88-4B6C-96FD-3EE87C74C081

Q37701607-0977EE08-A3F1-425B-B803-424A1BE214E2

Q37701607-0A347899-5732-4AAA-92BC-CC294A034FAE

Q37701607-0A9EB40E-83C2-4EDD-B996-CA1379F9D71D

Q37701607-1275E245-C7B6-430A-B9D2-97F302BB851C

Q37701607-16E92164-75C7-4C90-A423-8D396E1FBF5B

Q37701607-2267C207-66DA-4E9A-A2D7-5CDB49434E33

Q37701607-29C47434-5A94-4505-997B-4406846012C6

Q37701607-36FD9427-7264-4DDD-8D63-B5D4192DD40A

Q37701607-3E64C933-2DB0-4C2D-8368-42C70FFCF26F

P304

Q37701607-4428AAD7-FA87-44B8-9A6A-4274CD15E5AD

P31

Q37701607-F3627B30-C422-4EC7-B4CB-B944B9991EF0

P356

Q37701607-2EAA382A-4B7F-4460-89E6-BEE3BFAA498C

P407

Q37701607-5F55DF38-91A3-4E2A-8BCA-DE6737D85484

P433

Q37701607-12386FAA-D908-415A-8CA9-F2ACF23AF2AA

P478

Q37701607-FC63E4AD-F8A9-4DC1-AA12-96A110F25B5C

P577

Q37701607-CEF0A315-7676-4E65-8442-CA91554930F2

P698

Q37701607-FB41526C-9442-44AE-8819-19FD7ACA54D3

P921

Q37701607-4B4AE458-DEC4-4CDB-9703-DFB86ADCA7FD

P932

Q37701607-F830A6E4-177A-4775-A47C-6410D7EDBE77

P356

ONCOTARGET.14088

P1433

P1476

Radiolabeled novel mAb 4G1 for ...... nical glioblastoma xenografts.

@en

P2093

Bing Jia

http://www.w3.org/2001/XMLSchema#string

Chengyan Dong

http://www.w3.org/2001/XMLSchema#string

Fan Wang

http://www.w3.org/2001/XMLSchema#string

Jiyun Shi

http://www.w3.org/2001/XMLSchema#string

Li Shen

http://www.w3.org/2001/XMLSchema#string

Teng Ma

http://www.w3.org/2001/XMLSchema#string

Xujie Liu

http://www.w3.org/2001/XMLSchema#string

Zhaofei Liu

http://www.w3.org/2001/XMLSchema#string

Zhongxia Jin

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular Imaging

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

Untangling the ErbB signalling network

Specific and sensitive hydrolysis probe-based real-time PCR detection of epidermal growth factor receptor variant III in oral squamous cell carcinoma

Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials.

Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.

Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Growth suppression of human hepatocellular carcinoma xenografts by a monoclonal antibody CH12 directed to epidermal growth factor receptor variant III

Radioimmunotargeting of malignant glioma by monoclonal antibody D2C7 reactive against both wild-type and variant III mutant epidermal growth factor receptors

P304

6364-6375

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.14088

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28031526

http://www.w3.org/2001/XMLSchema#string

P921

P932

5351638

http://www.w3.org/2001/XMLSchema#string